These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 27889437)
1. Hypofractionation Is an Acceptable Alternative to Conventional Fractionation in the Treatment of Postlumpectomy Ductal Carcinoma In Situ With Radiotherapy. Isfahanian N; Al-Hajri T; Marginean H; Chang L; Caudrelier JM Clin Breast Cancer; 2017 Apr; 17(2):e77-e85. PubMed ID: 27889437 [TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast. Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719 [TBL] [Abstract][Full Text] [Related]
4. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576 [TBL] [Abstract][Full Text] [Related]
5. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy. Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378 [TBL] [Abstract][Full Text] [Related]
6. Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis. Rakovitch E; Narod SA; Nofech-Moses S; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Youngson B; Miller N; Done SJ; Sengupta S; Elavathil L; Jani PA; Bonin M; Metcalfe S; Paszat L Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):491-7. PubMed ID: 23708085 [TBL] [Abstract][Full Text] [Related]
7. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. ; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628 [TBL] [Abstract][Full Text] [Related]
8. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials. Jagsi R; Falchook AD; Hendrix LH; Curry H; Chen RC Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1001-9. PubMed ID: 25539365 [TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ--the influence of the radiotherapy boost on local control. Wong P; Lambert C; Agnihotram RV; David M; Duclos M; Freeman CR Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e153-8. PubMed ID: 21664063 [TBL] [Abstract][Full Text] [Related]
10. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543 [TBL] [Abstract][Full Text] [Related]
11. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study). De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035 [TBL] [Abstract][Full Text] [Related]
12. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843 [TBL] [Abstract][Full Text] [Related]
13. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943 [TBL] [Abstract][Full Text] [Related]
14. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy. Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102 [TBL] [Abstract][Full Text] [Related]
15. Accelerated partial breast irradiation for pure ductal carcinoma in situ. Park SS; Grills IS; Chen PY; Kestin LL; Ghilezan MI; Wallace M; Martinez AM; Vicini FA Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):403-8. PubMed ID: 20800374 [TBL] [Abstract][Full Text] [Related]
16. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ. Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of low-risk ductal carcinoma in situ in Southeast Asian women treated with breast conservation therapy. Wong FY; Wang F; Chen JJ; Tan CH; Tan PH Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):998-1003. PubMed ID: 24661651 [TBL] [Abstract][Full Text] [Related]
19. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage. Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441 [TBL] [Abstract][Full Text] [Related]
20. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]